FAQs
What is the primary role of a Market Access Manager at AstraZeneca?
The primary role involves leading pricing strategies, coordinating health technology assessment (HTA) submissions, securing national access for key therapeutic areas, and collaborating with various functions to support product launches.
What qualifications are required for this position?
A Bachelor's degree in Business, Economics, Public Health, or a related field is required; an advanced degree is preferred.
What experience is necessary for a candidate applying for this role?
Candidates should have extensive experience in pricing strategy within the pharmaceutical industry and a proven track record in HTA submissions and market access strategies.
What skills are essential for success in this job?
Strong analytical skills, excellent leadership and project management abilities, and a deep understanding of pharmaceutical pricing, health economics, and reimbursement landscapes are essential.
Who will a Market Access Manager collaborate with in this role?
The Market Access Manager will collaborate with various functions, including local and regional teams, national health stakeholders like the Department of Health and PhilHealth, and cross-functional teams.
What responsibilities are included in the management of HTA submissions?
Responsibilities include executing AstraZeneca's HTA submission plan, ensuring comprehensive submissions, coordinating with various functions for pricing approval and implementation, and managing post-submission requirements.
How does this role impact patient access to medicines?
The Market Access Manager plays a crucial role in securing national access for key therapeutic areas and products, which ultimately enhances patient access to life-changing medicines.
What type of reports will the Market Access Manager be expected to prepare?
The Market Access Manager will prepare regular reports to monitor KPIs and refine strategies related to market access initiatives.
What is the focus of AstraZeneca's market access initiatives?
The focus is on ensuring alignment with global pricing policies, securing national access for key therapeutic areas, and developing effective pricing and patient assistance programs.